Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-010080

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Geoffrey M. Parker
Officer — Executive Vice President & CFO
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 8:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 3, 2015A6,840$0.00A94,840D
Common StockF3holding———170,000ISee Footnote
Common StockF4holding———10,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F5$37.81Feb 3, 2015A28,400A—Feb 3, 2025Common Stock28,40028,400D
Performance Restricted Stock UnitsF6—Feb 3, 2015A6,930A——Common Stock6,9306,930D

Explanation of responses